News
Discussion about diminishing returns picked up momentum following OpenAI’s release of GPT-5. Other analysts say: Not so fast.
7h
TipRanks on MSNSonnet Biotherapeutics Faces Earnings Volatility with New HYPE Treasury Strategy and Accounting Standards
Sonnet Biotherapeutics Holdings, Inc. (SONN) has disclosed a new risk, in the Accounting & Financial Operations category. Sonnet Biotherapeutics ...
Anthropic is boosting the capacity of its Claude Sonnet 4 AI model, giving enterprise API customers the ability to send up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results